机器人辅助根治性前列腺切除术后的患者满意度与决策后悔分析
研究评估机器人辅助根治性前列腺切除术(RARP)后的治疗满意度和决策后悔,并与临床、人口学及生活质量指标关联。英国高通量中心207例患者中106例应答,48%完全满意,30%记录高度后悔,平均决策后悔量表评分11.3。高度后悔与问卷时间间隔、较高前列腺特异性生活质量症状评分及较低性功能和勃起功能评分相关。
要点
- RARP后约三分之一患者存在高度决策后悔,与较差疾病特异性生活质量和性功能相关。
- 术前应进行协作且详细的讨论,明确副作用对生活质量的长期影响。
- 决策后悔评估有助于识别需加强术前咨询的患者。
核心结论
- RARP后约30%患者记录高度决策后悔,且与较差疾病特异性生活质量、性功能和勃起功能相关。
研究设计与样本
- 研究为在英国高通量中心进行的回顾性问卷调查研究,纳入2011年6月至2016年5月间接受RARP的患者共207例,术后至少18个月通过邮寄问卷评估。
主要发现
- 106例应答者中,51例(48%)对接受RARP的决定完全满意,32例(30%)记录高度后悔。
- 平均决策后悔量表评分为11.3。
- 高度决策后悔与从RARP到问卷发放的时间长度、较高的前列腺特异性生活质量症状评分以及较低的性功能和勃起功能评分相关。
关键数值与推荐
- 决策后悔量表评分>15定义为高度决策后悔。
- 问卷包括EORTC QLQ-C30和PR25模块、男性性健康量表(SHIM)及Likert决策后悔量表。
临床怎么用
- 术前咨询应进行协作且详细的讨论,明确告知患者RARP副作用可能长期存在及其对生活质量的影响,以减少决策后悔。
局限性
- 研究为单中心回顾性设计,应答者仅106例(应答率约51%),可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess treatment satisfaction and decision regret post robot-assisted radical prostatectomy (RARP) and correlate these with clinical, demographic and quality of life indicators. Our study took place at a high-volume United Kingdom center and patients were assessed at a minimum of 18 months postsurgery. METHODS: Patients who underwent RARP between June 2011 and May 2016 were invited to participate through mailed questionnaires. A total of 207 patients formed our cohort. The questionnaires included European Organization for Research and Treatment of Cancer Quality of Life of Cancer patients 30 and PR25 modules, sexual health inventory in men and Likert decisional regret scale. A Decisional Regret Scale score of >15 was used to define an outcome of high decision regret. RESULTS: The mean patient age was 63 years and the mean duration of follow up was 36 months. Of the 106 responders, 51 (48%) were fully satisfied with the decision to undergo RARP and 32 (30%) recorded high regret. The mean Decisional Regret Scale score was 11.3. High decision regret associated with the length of time from RARP to questionnaire administration, higher prostate specific quality of life symptom scores and lower sexual and erectile function scores. CONCLUSION: Our study represents the first contemporary United Kingdom series assessing decision regret following the management of localised prostate cancer with RARP. Higher regret was seen in one third of patients and was associated with worse disease-specific quality of life, sexual and erectile function measures. To minimize regret, collaborative and detailed discussion should take place pre-operatively when counselling patients about RARP. The potential longevity and impact on quality of life of these side effects should be made clear.
引用
- Lindsay J, Uribe S, Moschonas D, et al. Patient Satisfaction and Regret After Robot-assisted Radical Prostatectomy: A Decision Regret Analysis. Urology. 2020. PMID: 33359493. doi:10.1016/j.urology.2020.12.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。